Lv62
2740 积分 2021-12-22 加入
Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology
19天前
已完结
Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
19天前
已完结
Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
19天前
已完结
Evaluation of Clinical and Safety Outcomes of Neoadjuvant Immunotherapy Combined With Chemotherapy for Patients With Resectable Esophageal Cancer
19天前
已完结
Lymph node metastatic patterns and the development of multidisciplinary treatment for esophageal cancer
19天前
已完结
MUC5B与PDCD4蛋白在肝内胆管细胞癌中表达的临床意义
1个月前
已完结
英夫利西单抗药物浓度及抗药物抗体检测在克罗恩病治疗中的临床应用
1个月前
已完结
CT-based body composition parameters predict the loss of response to infliximab in patients with Crohn's disease
1个月前
已关闭
Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study
1个月前
已完结
CT-based body composition parameters predict the loss of response to infliximab in patients with Crohn's disease
1个月前
已关闭
皖公网安备34019202002308
